Section 270.005 - Newborn Blood Screening Advisory Committee(A) The Commissioner shall establish a permanent advisory committee to advise the Department on matters pertaining to the Newborn Blood Screening Program including, but not limited to: (1) the listing of treatable diseases and disorders for which newborn blood screening should be mandated or offered as optional newborn blood screening;(2) how to best provide newborn screening services for the residents of the Commonwealth;(3) quality assurance and control measures utilized for the operation of the Newborn Blood Screening Program; and(4) new and emerging research in newborn screening.(B) Membership of the committee shall include, but not be limited to, parents and other consumers, practicing pediatricians, public health officials, neonatologists, obstetricians, clinicians and researchers specializing in newborn diseases and disorders, clinical geneticists, birth hospital representatives, Newborn Blood Screening Program professionals, medical ethicists, and other experts as needed to represent a variety of related fields such as emerging technologies and health insurance.(C) On an annual basis, the Newborn Blood Screening Program shall submit to the committee a report on the quality assurance and control measures utilized for the operation of the Newborn Blood Screening Program and the committee shall provide review and guidance on these measures.Amended by Mass Register Issue 1324, eff. 10/21/2016.